SUPN : Summary for Supernus Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Supernus Pharmaceuticals, Inc. (SUPN)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
23.45-0.05 (-0.21%)
At close: 4:00PM EST

23.45 0.00 (0.00%)
After hours: 4:00PM EST

People also watch
SCMPPCRXOMERRPTPHZNP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close23.50
Open23.55
Bid23.00 x 1000
Ask24.75 x 100
Day's Range23.10 - 23.80
52 Week Range9.51 - 27.50
Volume322,653
Avg. Volume537,443
Market Cap1.16B
Beta1.85
PE Ratio (TTM)47.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press44 minutes ago

    Supernus misses 3Q revenue forecasts

    The Rockville, Maryland-based company said it had net income of $1.18 per share. Earnings, adjusted for pretax gains, came to 36 cents per share. The drugmaker posted revenue of $56.8 million in the period, ...

  • Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : January 20, 2017
    Capital Cube11 hours ago

    Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Supernus Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth
    Investor's Business Daily5 days ago

    Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth

    See which stocks join Nvidia and Morgan Stanley on this list of companies expected to post stellar earnings growth for Q4.